Unknown

Dataset Information

0

Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.


ABSTRACT: We used a human cDNA macroarray containing various oncogenes and tumour suppressor genes to assess gene expression profiles in early-passage Jurkat T lymphocytes treated with clinically relevant concentrations of the antitumour antibiotic daunorubicin. Several oncogenes and tumour suppressor genes were either up- or down-regulated depending on the daunorubicin concentration used. The expression levels of some of these genes were confirmed by semi-quantitative reverse transcriptase-PCR. We also compared the changes in cell-cycle distribution and the apoptotic morphological characteristics of the cells treated with daunorubicin, using flow cytometry and fluorescence microscopy. Exposure to 182 nM daunorubicin (its IC(75) in Jurkat T cells: where IC(75) is the drug concentration that inhibits growth by 75%) resulted in cell-cycle arrest in G(1) and almost immediate apoptosis. In contrast, decreasing the drug concentration to 91 nM (close to the IC(50)) caused G(2) arrest and cell senescence-like growth arrest, whereas features of apoptosis and necrosis appeared only after longer incubation times. Gene expression profiles, cell-cycle distribution, the presence of DNA damage and the time-dependent response of Jurkat T cells to cell death were correlated clearly. The general behaviour of the genes suggests that cell-cycle arrest and cell death follow distinct pathways depending on drug concentration.

SUBMITTER: Mansilla S 

PROVIDER: S-EPMC1223450 | biostudies-literature | 2003 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.

Mansilla Sylvia S   Piña Benjamin B   Portugal José J  

The Biochemical journal 20030601 Pt 3


We used a human cDNA macroarray containing various oncogenes and tumour suppressor genes to assess gene expression profiles in early-passage Jurkat T lymphocytes treated with clinically relevant concentrations of the antitumour antibiotic daunorubicin. Several oncogenes and tumour suppressor genes were either up- or down-regulated depending on the daunorubicin concentration used. The expression levels of some of these genes were confirmed by semi-quantitative reverse transcriptase-PCR. We also c  ...[more]

Similar Datasets

| S-EPMC4849064 | biostudies-literature
| S-EPMC3229606 | biostudies-literature
| S-EPMC3230376 | biostudies-literature
| S-EPMC8070730 | biostudies-literature
| S-EPMC3899331 | biostudies-literature
| S-EPMC8304976 | biostudies-literature
| S-EPMC1952086 | biostudies-literature
| S-EPMC5216721 | biostudies-literature
| S-EPMC3688046 | biostudies-literature
2024-07-22 | GSE271459 | GEO